CAR T cell therapy targets key mutation driving rare blood cancers
A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving ...
1 Jul 18:00 · Medical Xpress